Cardiovascular safety of Janus kinase inhibitors in patients with rheumatoid arthritis: systematic review and network meta-analysis
- DOI
- 10.3389/fphar.2023.1237234
- Published
- 2023-08-08
- Container
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fphar.2023.1237234,
title = {Cardiovascular safety of Janus kinase inhibitors in patients with rheumatoid arthritis: systematic review and network meta-analysis},
author = {Qige Wei and Hui Wang and Jianglin Zhao and Zhongping Luo and Chufeng Wang and Chunmei Zhu and Na Su and Shengzhao Zhang},
year = {2023},
journal = {Frontiers in Pharmacology},
doi = {10.3389/fphar.2023.1237234},
url = {https://doi.org/10.3389/fphar.2023.1237234}
}RIS
TY - JOUR TI - Cardiovascular safety of Janus kinase inhibitors in patients with rheumatoid arthritis: systematic review and network meta-analysis AU - Qige Wei AU - Hui Wang AU - Jianglin Zhao AU - Zhongping Luo AU - Chufeng Wang AU - Chunmei Zhu AU - Na Su AU - Shengzhao Zhang PY - 2023 JO - Frontiers in Pharmacology DO - 10.3389/fphar.2023.1237234 UR - https://doi.org/10.3389/fphar.2023.1237234 ER -
APA
Wei, Q., Wang, H., Zhao, J., Luo, Z., Wang, C., Zhu, C., Su, N., & Zhang, S. (2023). Cardiovascular safety of Janus kinase inhibitors in patients with rheumatoid arthritis: systematic review and network meta-analysis. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2023.1237234
Source records
- crossref · retrieved 2026-09-27T07:15:52.958Z